Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H15N5.C2H6O3S |
Molecular Weight | 351.424 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCS(O)(=O)=O.CC(C)CN1C=NC2=C1C3=NC=CC=C3N=C2N
InChI
InChIKey=CLPJOVGTNBZYQJ-UHFFFAOYSA-N
InChI=1S/C13H15N5.C2H6O3S/c1-8(2)6-18-7-16-11-12(18)10-9(17-13(11)14)4-3-5-15-10;1-2-6(3,4)5/h3-5,7-8H,6H2,1-2H3,(H2,14,17);2H2,1H3,(H,3,4,5)
Molecular Formula | C13H15N5 |
Molecular Weight | 241.2917 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C2H6O3S |
Molecular Weight | 110.132 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Epetirimod (S-30563 or TAK-851) is an immunostimulant. The compound is structurally related to the marketed topical imidazoquinoline drug, imiquimod, an agonist of Toll-like receptor 7. Epetirimod was under development with Takeda Pharmaceutical as a topical treatment for cervical high-risk HPV infection and cervical dysplasia. Takeda has discontinued epetirimod development as it did not meet the predefined efficacy end points in a US Phase II trial.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:30:43 GMT 2023
by
admin
on
Sat Dec 16 00:30:43 GMT 2023
|
Record UNII |
P05864B14S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID501008220
Created by
admin on Sat Dec 16 00:30:43 GMT 2023 , Edited by admin on Sat Dec 16 00:30:43 GMT 2023
|
PRIMARY | |||
|
P05864B14S
Created by
admin on Sat Dec 16 00:30:43 GMT 2023 , Edited by admin on Sat Dec 16 00:30:43 GMT 2023
|
PRIMARY | |||
|
11653228
Created by
admin on Sat Dec 16 00:30:43 GMT 2023 , Edited by admin on Sat Dec 16 00:30:43 GMT 2023
|
PRIMARY | |||
|
300000044462
Created by
admin on Sat Dec 16 00:30:43 GMT 2023 , Edited by admin on Sat Dec 16 00:30:43 GMT 2023
|
PRIMARY | |||
|
885483-02-3
Created by
admin on Sat Dec 16 00:30:43 GMT 2023 , Edited by admin on Sat Dec 16 00:30:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |